FDA inspection

Eli Lilly Italia SPA: FDA inspection ending Nov 5, 2021

FDA inspection 1156927 · No Action Indicated (NAI) · Sesto Fiorentino

Key facts

Inspection ID 1156927
Firm Eli Lilly Italia SPA
FEI number 3002806895
Address Via Antonio Gramsci 731/733
City Sesto Fiorentino
Fiscal year 2022
Inspection end date Nov 5, 2021
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections